Hoppen, L., Sarria, G. R., Kwok, C. S., Boda-Heggemann, J., Bürgy, D., Ehmann, M., . . . Fleckenstein, J. (2023). Dosimetric benefits of adaptive radiation therapy for patients with stage III non-small cell lung cancer. Radiation oncology, 18, . https://doi.org/10.1186/s13014-023-02222-7
Chicago-Zitierstil (17. Ausg.)Hoppen, Lea, Gustavo R. Sarria, Chung S. Kwok, Judit Boda-Heggemann, Daniel Bürgy, Michael Ehmann, Frank Anton Giordano, und Jens Fleckenstein. "Dosimetric Benefits of Adaptive Radiation Therapy for Patients with Stage III Non-small Cell Lung Cancer." Radiation Oncology 18 (2023). https://doi.org/10.1186/s13014-023-02222-7.
MLA-Zitierstil (9. Ausg.)Hoppen, Lea, et al. "Dosimetric Benefits of Adaptive Radiation Therapy for Patients with Stage III Non-small Cell Lung Cancer." Radiation Oncology, vol. 18, 2023, https://doi.org/10.1186/s13014-023-02222-7.